KIT and soft tissue sarcoma: Also included in this analysis as positive and negative controls were the canine C2 mast cell line, with an internal tandem duplication that activates c-Kit, and the canine STSA-1 soft tissue sarcoma cell line with an inactivating frameshift mutation in NF-120.